Attached files
| file | filename |
|---|---|
| EX-10.21 - EXHIBIT 10.21 - Mirati Therapeutics, Inc. | mrtx-20161231xex1021.htm |
| EX-32.1 - EXHIBIT 32.1 - Mirati Therapeutics, Inc. | mrtx-20161231xex321.htm |
| EX-31.2 - EXHIBIT 31.2 - Mirati Therapeutics, Inc. | mrtx-20161231xex312.htm |
| EX-31.1 - EXHIBIT 31.1 - Mirati Therapeutics, Inc. | mrtx-20161231xex311.htm |
| EX-10.25 - EXHIBIT 10.25 - Mirati Therapeutics, Inc. | mrtx-20161231xex1025.htm |
| EX-10.24 - EXHIBIT 10.24 - Mirati Therapeutics, Inc. | mrtx-20161231xex1024.htm |
| EX-10.23 - EXHIBIT 10.23 - Mirati Therapeutics, Inc. | mrtx-20161231xex1023.htm |
| EX-10.22 - EXHIBIT 10.22 - Mirati Therapeutics, Inc. | mrtx-20161231xex1022.htm |
| EX-10.20 - EXHIBIT 10.20 - Mirati Therapeutics, Inc. | mrtx-20161231xex1020.htm |
| 10-K - 10-K - Mirati Therapeutics, Inc. | mrtx-20161231x10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) | Registration Statement (Form S-3 No. 333-207848) of Mirati Therapeutics, Inc., |
(2) | Registration Statement (Form S-3 No. 333-206965) of Mirati Therapeutics, Inc., |
(3) | Registration Statement (Form S-3 No. 333-198678) of Mirati Therapeutics, Inc., |
(4) | Registration Statement (Form S-8 No. 333-204720) pertaining to the 2013 Equity Incentive Plan of Mirati Therapeutics, Inc., |
(5) | Registration Statement (Form S-8 No. 333-189965) pertaining to the Amended and Restated Incentive Stock Option Plan, 2013 Equity Incentive Plan, and 2013 Employee Stock Purchase Plan of Mirati Therapeutics Inc., and |
(6) | Registration Statement (Form S-8 No. 333-196487) pertaining to the 2013 Equity Incentive Plan of Mirati Therapeutics Inc.; |
of our report dated March 9, 2017, with respect to the consolidated financial statements of Mirati Therapeutics, Inc. included in this Annual Report (Form 10-K) of Mirati Therapeutics, Inc. for the year ended December 31, 2016.
/s/ Ernst & Young LLP | ||||
San Diego, California | ||||
March 9, 2017 | ||||